(Bloomberg) -- Alphabet Inc.'s Isomorphic Labs is in talks to raise roughly $5 billion in new funds to support its efforts to use artificial intelligence for drug discovery, according to people familiar with the matter. Most Read from Bloomberg Morgan Stanley Offers $2.3 Billion Debt for Dell Family Deal Democrats Clinch Huge Wins on Inflation Anger, Trump Fatigue What the Democrats' Sweep of Congress Means for Trump Democrats Sweep to Control of Congress in Rebuke of Trump Democrat El-Sayed Wins Michigan Race in Boost to Progressives The round would value Isomorphic, which spun out of Alphabet's Google DeepMind, at about $50 billion, said the people, who spoke on condition of anonymity as the information is not public.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.